chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within 30 minutes I experienced extreme anxiety.  Extreme stress that made no sense at all.  This lasted for about three hours before subsiding.  It is hard to explain how upsetting this was.  My brain was super stressed.  I also experienced heavy legs with tingling in the feet and a brief period of dizziness.  I was able to prevent a fall and this passed very quickly, within minutes.
Fever, chills shortness of breath.  He took tylenol on sunday and then was ok monday morning.  monday afternoon breathing got worse. He went to the ER on tuesday morning
Pt developed pain in the left groin  after 3 days. Patient had a venous doppler and is diagnosed with DVT of the left anterior tibial vein
Have had constant numbness in both hands, shoulders when used, hips upon rising from sitting position. This has been continuous since 5 days after receiving the first Pfiser vaccination on 2/27/21. After the second shot on 3/20/21 (lot# er2613) The pain has been constant but particularly in the morning when I sometimes need help to put on my dress shirt (shoulder pain), pull on my socks (weakness in my thumbs) and find it difficult to tie my shoes due to weakness in my hands.
Gave 3 booster doses  of Lot # that expired on the 12Apr2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave 3 booster doses  of Lot # that expired on the 12Apr2022.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave 3 booster doses  of Lot # that expired on the 12Apr2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave 3 booster doses  of Lot # that expired on the 12Apr2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.   The reporter stated that they were administering Moderna COVID-19 vaccines and stated that they gave 3 booster doses that expired on the 12 Apr 2022. The HCP was unable to provide any additional details about the patients except that it was their 2nd booster dose. On 08 Apr 2022 the vial was initially stored in the refrigerator.   Reporter did not allow further contact
pt recvd vax & 1 wk post vax pt exp a gen rash;no further details were provided;
Chest pains and increased heart rate. Took Advil and got as much rest as possible. Pains went away the next morning.
6 MALES WERE ADMINISTERED 0.3ML OF JANSSEN COVID 19 VACCINE; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The drug was associated with Medication error. No concomitant medications were reported. On an unspecified date, the patient experienced 6 males were administered 0.3ml of janssen covid 19 vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 6 males were administered 0.3ml of janssen covid 19 vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20220626380.
This initial spontaneous case, was received from other health professional (nurse) on 27-Oct-2017, concerning a 56-year-old adult female patient. The patient's medical history included osteoarthritis (unspecified date). The patient's concomitant medications include glucosamine and ibuprofen for an unknown indication. On 09-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 195237, expiry date: May-2018. On the same day, the patient had a pain, which described as stinging throbbing began during administration of the vaccine, little bleeding after the injection, which stopped in 2 minutes, quarter size welt hard spot started at the injection site. The welt resolved within 24-hours. The patient also had a bruise at the injection site, which resolved after 2 weeks. The same day (09-Oct-02017). The patient also developed injection site lump. No treatment medication was taken for the events. At the time of this report, the patient recovered from all the events. The reporter assessed the events as non-serious. Follow-up received on 22-Nov-2017: Added new event injection site lump. The outcome of the event slight pain was changed from not recovered to recovered. The event bruising was changed to injection site bruising. The narrative was amended accordingly. Non-significant follow up received on 04-Dec-2017: The reporter confirmed the start date of the event injection site lump as 09-Oct-2017.
Joint pain; had liquid diarrhea; Stomach not crampy but urgency when it happens; Medical history include coeliac disease; This is a spontaneous report from a contactable consumer (patient). A 68-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9262; expiration date: unknown), via an unspecified route of administration right arm on 23Jan2021 11:00 at a single dose for covid-19 immunization. Medical history included essential tremor, coeliac disease, high blood pressure, and allergies to wheat and dairy. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included enalapril (ENALAPRIL), venlafaxine hydrochloride (EFFEXOR), propranolol and hydrochlorothiazide (HCT). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported for about a week, she has had liquid diarrhea. The patient also has joint pain, stomach not crampy but urgency when it happens and no fever. The patient did not received treatment for the adverse events and the event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The onset of the events was on 26Jan2021 and the outcome of the events was not recovered.
A spontaneous report has been received from a Health Professional concerning a 53 year old, female subject, who had been receiving FLUMIST Quadrivalent, 0.2 ml pre-filled single dose sprayer. FLUMIST Quadrivalent  started on an unknown date. The patient experienced administered FLUMIST Quadrivalent to a 53 yo which started on 24-OCT-2014. The outcome of the event of administered FLUMIST Quadrivalent to a 53 yo is unknown. The report was considered to be non-serious.
fever; body aches; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical History).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PYREXIA (fever), PAIN (body aches), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Blisters, pruritis, urticaria on palms of hands. Primarily on right hand, scant on left hand. Pt reports self treating with cortisone cream with minimal relief. Will continue to monitor and assess. Instructed pt to f/u with PCP if the condition does not resolve or gets worse.
Occasional warm sensation in the left thigh, started when I received the Moderna booster and could feel it for days after. I called the Healthcare (vaccine provider and my healthcare provider) to see if I should see a doctor because I was concerned about blood clots, they had the on-call doctor call me back. When I explained that I had just the warm sensation in the thigh without pain or swelling he advised that I wait to see a doctor in person and that I shouldn't be concerned of a blood clot because there hadn?t been any associated with the Moderna vaccine. I am still feeling the warm sensation in the same spot.
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medications were not reported. On 30-JUN-2017, the patient was inadvertently vaccinated with PROQUAD lot # M038861 and expiry date: 13-MAR-2018; for prophylaxis instead of M-M-R II. The refrigerator was labeled M-M-R II, however, PROQUAD was placed in it. There were no temperature excursions. The call was due to a digital data logger. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Pt got a severe raised rash on chest that was itchy, burning and red. it lasted 6 weeks. It is now spotted. She said it did not weep or have liquids. The doctor told her it is most likely from the ZOSTAVAX.
after about an hour of the injection I started having  severe dizziness, severe tachycardia both arms had muscle cramping and my fingers curled up like muscle spasm. I also suffered from a sense of scratchiness in my throat and a metallic penny sort of taste in my mouth. These symptoms resided about three hours later.
Her fever is 103; Vomiting; Nauseated; This is a spontaneous report recieved from a contactable consumer (husband) reported for a 38-year-old female wife(patient) reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), via an unspecified route of administration, administered in Arm Right on 07Apr2021 10:30 (Batch/Lot Number: ER8737) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 07Apr2021 15:30, the patient experienced her fever is 103, nauseated and vomiting. Caller was reporting on behalf of his wife. They both just got the Covid-19 Vaccine earlier today at around 10:30. Right now it was 16:00. It seems like his wife was experiencing some side effects, and he wanted to call to confirm and report it. She was nauseated and unwell. She has a fever, and he took her temperature several times just now. She vomited as well. She became nauseated about one hour ago. It got worse and is causing her to throw up. She threw up 3 different times in the last 30 to 40 minutes. Her fever was 103. He asks if that temperature was considered an emergency. It seemed fever as a common thing on the list about the risks, but he doesn't know about 103. Referred caller to his wife's physician for medical advice. The outcome of the events was reported as not recovered.  No follow-up attempts are needed. No further information is expected.
pain on the arm at the location of where the vaccine was administered; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team for a Pfizer sponsored program (159558).  A female patient received BNT162B2, administration date 15Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Mar2021, described as "pain on the arm at the location of where the vaccine was administered".  Additional information: The patient's husband reported that the patient and him got the covid vaccine yesterday. They were both good but had pain on the arm at the location of where the vaccine was administered. He stated that the pain was not bad, and just wanted to check to see if they can take Tylenol or Ibuprofen to relive the pain.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021300209 same reporter/drug/event, different patient
A few hrs after HPV #1 vaccine, pt was in school & developed uncontrollable shaking, laughing, then crying, then curled up in a ball on floor. She had no control over her emotions x 45 min. Pt's dad observed this behavior. 4/24 Next day, pt felt like "in a fog"; again felt "shaky" & unable to hold a pencil; also devel. headache lasting until 4/25 -> today felt WNL.
Past lot that had also been expired that was administered to patients; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to patients) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065F21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Past lot that had also been expired that was administered to patients).    No concomitant medications were reported. Treatment information was not provided.
The patient was set to receive the second dose of the series on 1/25/21 and instead received it on 1/19/21. The patient experienced a headache and chills lasting a few hours. The patient also reported redness/itchiness/warmth at the injection site for 72 hours following the injection.
Headache, Arthralgia, Phlebitis, Fever, Injection site site pain and chills Narrative: Day 1-2, chills, headache, fever 101, bodty aches , resolved within 48 hours. Day 1- current Injection site pain continues, still has pain with movement and pulling/pushing.
Patient got dizzy and fainted a few minutes after receiving shot, once she came to she then proceeded to vomit. The immunizer is a RN and attended to the patient until paramedics arrived. Paramedics monitored symptoms and blood pressure until all levels were normal
Patient was administered an extra dose of the Pfizer 5-11 monovalent COVID-19 vaccine instead of the intended Pfizer 5-11 Bivalent Booster COVID-19 vaccine on 12/4/22 at 10:10am.   I called and informed patient's mother on 12/5/22 and she reported that patient is doing well except for some mild expected post-vaccination symptoms.
Wrong  vaccine given to the patient, pt was in the clinic for flu shot and received moderna covid vaccine instead
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 5 (booster), single (Lot number: GH9694), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 02Feb2021 as dose 1, single (Lot number: EL3302), in left arm, on 23Feb2021 as dose 2, single (Lot number: EL9263), in left arm, on 04Oct2021 as dose 3 (booster), single (Lot number: FC3184), in left arm and on 23May2022 as dose 4 (booster), single (Lot number: FK9894), in left arm for covid-19 immunisation. The patient's relevant medical history included: "environmental allergies" (unspecified if ongoing); "Known allergies: sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID-19 treatment; Positive, notes: tested positive after completing Paxlovid treatment regimen. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included PAXLOVID from 01Jan2023 to 06Jan2023. No follow-up attempts are possible. No further information is expected.
Patient presented with moderate headache and blurred vision approximately 26 hours after receiving boosters on Varicella and Hepatitis B. Physician ordered some basic lab work after examining child and finding no obvious neurological cause. Diagnosis of possible pediatric migraine was made. Lab results have not yet been returned. Patient went home and developed low-grade fever of 99.4 degrees farenheit (axillary temp), and was given 200mg ibuprofen. Symptoms disappeared after about one hour. Child awoke at 3AM with much higher fever (100.8 axillary) and complained that headache had returned and that his upper body and limbs ached. A second dose of ibuprofen was given, along with about 8oz. of  oral electrolyte solution (Gatorade). Patient returned to bed, but complained of being unable to sleep.
On 8/9/12 child complained of nausea & headache - TYLENOL given & felt better & went to school. Night of 8/9/12 area around the injection site had swelling, redness, hardness, & hot to touch - gave BENADRYL & MOTRIN. 8/10/12 - swelling, redness, & hot to touch was down front of (L) arm - taken to walk in clinic & prescribed prednisolone 15 mg x 10 days. Mother states injection site was "upper (L) arm below the shoulder."
Menveo powder reconstituted with sterile water; administered the powder component of Menveo  reconstituted with sterile water; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA765A) for prophylaxis.   On 29-JUN-2023, the patient received Menveo. On 29-JUN-2023, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menveo powder reconstituted with sterile water) and inappropriate dose of vaccine administered (Verbatim: administered the powder component of Menveo  reconstituted with sterile water). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 03-JUL-2023 The nurse stated that on 29 June 2023 another staff member administered the powder component of Menveo after it was reconstituted with sterile water. Menveo reconstituted with sterile water instead of the supplied CYW-135 liquid conjugate, which led to Wrong solution used in drug reconstitution and Inappropriate dose of vaccine administered. The reporter declined to provide patient information. The Vaccine Administration Facility is the same as Primary Reporter. The reporter did not consent to follow up.
Swelling, redness of right thigh (over site of DTaP immunization). No other systemic complaints/findings.
This spontaneous report was received from a physician and from a support services director and refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On 09-SEP-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection (lot # J011042, expiry date: 04-MAR-2015; exact dose and route of administration were not reported). There were no concomitant therapies reported. On an unknown date, the dose of the vaccine was exposed to the temperature excursion lasting 3024 hours with the lowest recorded temperature of 20 degrees Fahrenheit (-6.66 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Extreme body aches and pains, Headache, Fatigue, Nausea, Chills.
Within an hour of receiving the vaccine, I felt pressure & pain at the injection site. It was difficult to raise my hand to eat. I felt intense pain for several hours after injection.
Patient went to emergency room due to swelling of arm and experiencing some pain. Was given a course of antibiotics for an infection.
PT RECEIVED VARIVAX ON 1-14-2002 AND 3-3-2009. PT PRESENTED IN THE OFFICE ON 6-17-2009 WITH 25-30 SCATTERED MACULAR LESIONS WITH SOME PAPULAR CENTERS ON BACK AND 10-12 LESIONS ON BUTTOCKS. STARTED WITH TEMP OF 102-103 ON 6-15-2009.
Patient with generalized weakness and concern for vulnerable adult status. Rapid Covid was positive, and she received the monoclonal antibody in the emergency room. She continues to have weakness so she will be transferred over to swing bed status today for ongoing PT and OT. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Saturday morning was incredibly fatigued, running 100 degree fever, constant headache. Ibuprofen helped but only marginally. As of Monday sept 27 fever has not receded without administering 600mg ibuprofen every 4 hrs. Throat is incredibly sore and beginning of ear infection in right ear. I was totally healthy before the shot.
Immediate Itchy, swollen lips and tongue. Nose got itchy as time went on. Sweaty palms and armpits. Flush face, blotches on neck. Hoarse voice. Hot feeling.
Pt had an injection site reaction to his flu vaccine. Pt presented 3 days post flu shot with small lesion, slight amount of exudate. Pt was advised to be seen at physicians office. Culture was done. Flu 1 week later, CK was negative and lesion was healing.
One minute after vaccination patient began to develop urticaria on his upper anterior chest. Patient complained of dry mouth and throat and "not feeling well". Patient was given 50mg of PO benadryl. Rash on chest resolved but swelling began in face around eyes, and blanchable redness developed on forehead and patient complained of itching scalp and nausea. 24 mg of methylprednisolone and 8mg of Zofran was administered. Patient maintaining a normotensive state throughout events, hr in the 70s and oxygen saturation 96%. at 0910 patient had returned a normal state, no signs of swelling or difficulty breathing. Fire team was called for evaluation and patient was observed for one hour. No return of symptoms.